Separation of digoxin, digitoxin and their potential metabolites, impurities or degradation products by high-performance liquid chromatography

Preconcentration of digoxin using a synthetic imprinted polymer deposited upon the surface of double-layered hydroxides on porous anodised aluminium wire a triple solid-phase microextraction fibre

INTRODUCTION

A new solid-phase microextraction fibre is fabricated through polymerisation of molecularly imprinted polymer on the surface of a layered double hydroxide framework that has been fabricated via the in situ synthesis on a non-porous anodic aluminium oxide/aluminium wire as both the substrate and the aluminium source.

OBJECTIVE

The synthesized SPME fiber was performed to analyze trace digoxin in real samples.

MATERIAL AND METHOD

A one-at-a-time optimization strategy was applied for optimizing the important extraction parameters such as extraction solvent, extraction time, stirring rate, pH, ionic strength, and desorption time.

RESULT

Aluminum surface before and after anodizing and LDH structure reveal that anodizing and preparation LDH increases the surface area and adsorption capacity of aluminum wire.

CONCLUSION

Under optimum conditions, the repeatability for one fibre (n = 3), expressed as relative standard deviation (RSD %), was 5.2%.

Simultaneous determination of various cardiac glycosides by liquid chromatography-hybrid mass spectrometry for the purity assessment of the therapeutic monitored drug digoxin

A high performance liquid chromatography-hybrid tandem mass spectrometry (LC-MS(n)) method utilising electrospray ionisation has been developed and implemented for the simultaneous determination of several cardiac glycosides (CGs) as well as their corresponding aglycones formed by and extracted from herbaceous plants of the genus Digitalis. The method has been validated in-house and its performance characteristics (linearity, repeatability, limits of detection, etc.) were assessed for use in the quantification of CGs and their corresponding aglycones. LODs from 38 to 936pgg(-1) in solution, corresponding to mass fraction impurity levels from 0.0009 (or 0.00008%) to 0.019mgg(-1) (or 0.0019%) detectable in the pure materials have been realized. Moreover, the method was used to characterize and to determine the inherent CG impurities in batches of the therapeutic monitored drug digoxin which served as candidate reference material for an organic purity assessment inter-laboratory study (CCQM-P20.f) organised by the BIPM Chemistry Section and carried out within the framework of the Organic Analysis Working Group (OAWG) of the Consultative Committee for Amount of Substance - Metrology in Chemistry (CCQM). Digoxin was selected from materials required for the establishment of reference measurement systems for clinical chemistry and laboratory medicine.

Validation of an HPLC-UV method for the determination of digoxin residues on the surface of manufacturing equipment

In the pharmaceutical industry, an important step consists in the removal of possible drug residues from the involved equipments and areas. The cleaning procedures must be validated and methods to determine trace amounts of drugs have, therefore, to be considered with special attention. An HPLC-UV method for the determination of digoxin residues on stainless steel surfaces was developed and validated in order to control a cleaning procedure. Cotton swabs, moistened with methanol were used to remove any residues of drugs from stainless steel surfaces, and give recoveries of 85.9, 85.2 and 78.7 % for three concentration levels. The precision of the results, reported as the relative standard deviation (RSD), were below 6.3 %. The method was validated over a concentration range of 0.05-12.5 ?g mL-1. Low quantities of drug residues were determined by HPLC-UV using a Symmetry C18 column (150?4.6) mm, 5 ?m) at 20?C with an acetonitrile-water (28:72, v/v) mobile phase at a flow rate of 1.1 mL min-1, an injection volume of 100 ?L and were detected at 220 nm. A simple, selective and sensitive HPLC-UV assay for the determination of digoxin residues on stainless steel was developed, validated and applied.

HPLC method with UV detection for evaluation of digoxin tablet dissolution in acidic medium after solid-phase extraction

A simple and reliable method for the evaluation of dissolution of digoxin tablets in 0.01 M hydrochloric acid was developed. Digoxin and its degradation products after solid-phase extraction using C18 Sep-Pak cartridges were evaluated. Analyses were performed on C18 column (LiChrospher RP-18e, 5 microm, 125 x 4.0 mm), as mobile phase water and acetonitrile (72:28, v/v) were used. Detection wavelength was 218 nm. Identity of digoxin degradation products was confirmed by HPLC-MS.

High-performance liquid chromatographic determination of alpha-acetyldigoxin in Digitalis lanata leaves

An analytical method for the determination of alpha-acetyldigoxin in Digitalis lanata leaves by HPLC has been developed. The procedure consists of extraction of dry leaf powder with 50% methanol and cleanup by a Sep-Pak C18 cartridge prior to HPLC analysis. The quantitation is carried out by the incorporation of beta-methyldigoxin as an internal standard. HPLC is performed on an octylsilyl bonded silica column with acetonitrile/methanol/water (100/11/188, v/v). The effluent is monitored by uv absorption at 220 nm. The amount of alpha-acetyldigoxin per 100 mg of dry leaf powder is estimated at 5.55 +/- 0.21 micrograms (mean +/- SD). The average recovery of alpha-acetyldigoxin from added samples is 97.2%. The present method is sensitive, reliable, and relatively simple. Application of this HPLC method to the analysis of samples obtained by fermentation of the leaf powder is also demonstrated.

Determination of deslanoside in antemortem and postmortem specimens. Unusual case report

One case of the erroneous administration of deslanoside and high level of drug in antemortem plasma and postmortem specimens has been reported owing to the unusual surrounding circumstances. Deslanoside in antemortem plasma was determined by FPIA and the analysis was done by HPLC in the postmortem tissue samples. The analytical results and methods used in the examinations are discussed in the following paper.

Development of a high-performance liquid chromatographic assay for digoxin using post-column fluorogenic derivatization

An efficient high-performance liquid chromatographic (HPLC) separation for digoxin and its metabolites has been developed. Quantitation of digoxin at plasma levels was possible after the column effluent was passed through a fluorogenic post-column reactor. A study of the optimum post-column conditions was undertaken using a combination of ascorbic acid, hydrogen peroxide and hydrochloric acid, which was known to induce fluorescence in the digoxin molecule. Digoxin and its metabolites were separated on a 15 cm X 4.6 mm I.D., 3-microns reversed-phase (C18) HPLC column using methanol--ethanol--isopropanol--water (52:3:1:45) as the mobile phase at a flow-rate of 0.3 ml/min. A solution of 1.1 X 10(-3) M hydrogen peroxide in a 0.1% ascorbic acid solution and concentrated hydrochloric acid were added into the post-column reactor through a peristaltic pump at a combined flow with a flow-rate of 0.23 ml/min. The mixture was passed into the 20-m reaction coil maintained at 79 +/- 1 degrees C. The resulting digoxin fluorophore was monitored with a fluorescence detector. Detector responses were linear from 1.5 to 10 ng injected on-column. The overall performance demonstrated that this system has the sensitivity, linearity and stability desired in a digoxin plasma level determination. The total chromatographic time including the postcolumn derivatization step was about 40 min.

Detection of digoxin, digitoxin, their cardioactive metabolites and derivatives by high-performance liquid chromatography and high-performance liquid chromatography-radioimmunoassay

High-performance liquid chromatographic (HPLC) systems are described for the separation of the cardioactive metabolites of the digoxin and digitoxin series that are formed by the splitting of digitoxose sugar residues from the aglycone steroid: isocratic separation of digoxin and its cardioactive metabolites; isocratic separation of digitoxin and its cardioactive metabolites; and gradient elution separation of the digoxin and digitoxin series including beta-acetyl- and beta-methyldigoxin. Separations were performed on a 10-microns bonded octadecyl phase column using various mixtures of acetonitrile--water and acetonitrile--methanol--water as the mobile phase. These methods provide high peak resolution and are well suited for collecting elution fractions, e.g. to link up with sensitive immunological measurements. An HPLC-radioimmunoassay method is described for the quantitation of digoxin, digitoxin and their metabolites in human tissues.

Metabolic and drug profiling

Over recent years, advances in analytical technology have greatly improved our ability to study the metabolism of compounds from either endogenous or erogenous sources. The application of gas-liquid chromatography, mass spectrometry, high-performance liquid chromatography and immunological approaches are discussed in relation to the analysis of steroids, bile acids, organic acids, prostaglandins, porphyrins and bile pigments, amino acids, proteins, nucleotides, catecholamines, vitamins and drugs.